InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the complete record of transactions filed by Lee Christopher G, Directeur Scientifique. Officer active across 1 companies, notably Apria, Inc.. Aggregated, 13 filings have been recorded. Total volume traded: €140k. The latest transaction was disclosed on 10 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
02,261 shares0
Common Stock
SEC:0000899243-22-011317:0·
€19,5922,700 shares@ €7.256416.1% of flow
Common Stock
SEC:0000899243-22-002758·
€19,5922,700 shares@ €7.25648.1% of flow
Common Stock
SEC:0000899243-22-002758:0·
€24,731954 shares@ €25.923920.3% of flow
Common Stock
SEC:0000899243-21-048974·
€24,731954 shares@ €25.923910.2% of flow
Common Stock
SEC:0000899243-21-048974:0·
€19,7632,700 shares@ €7.319816.2% of flow
Common Stock
SEC:0000899243-21-048387·
€19,7632,700 shares@ €7.31988.1% of flow
Common Stock
SEC:0000899243-21-048387:0·
€1,412346 shares@ €4.08161.2% of flow
Common Stock
SEC:0000899243-21-045182·
€1,412346 shares@ €4.08160.6% of flow
Common Stock
SEC:0000899243-21-045182:0·
€45,4241,524 shares@ €29.805637.3% of flow
Common Stock
SEC:0000899243-21-041426·
€45,4241,524 shares@ €29.805618.7% of flow
Common Stock
SEC:0000899243-21-041426:0·
€10,7552,700 shares@ €3.98358.8% of flow
Common Stock
SEC:0000899243-21-040821·
€10,7552,700 shares@ €3.98354.4% of flow
Common Stock
SEC:0000899243-21-040821:0·
13 of 13 declarations
About Lee Christopher G
Ruben Tommasi serves as Chief Scientific Officer at Entasis Therapeutics Holdings Inc. In this role, he is responsible for leading the company's research and development activities. Ruben plays a key role in innovation and the development of new therapies to meet patient needs.
